Delivery Order SPE2DB25D3306-SPE2DB26FUAPC
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $26,519.00 to AmerisourceBergen Drug Corp for the supply of SCEMBLIX 40 MG tablets (60-count units). This firm fixed-price delivery order, issued on July 14, 2025, with completion targeted for August 4, 2025, represents a competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical federal...
- The Defense Logistics Agency awarded a $26,519 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SCEMBLIX 40 mg tablets (60-count units) on September 3, 2025, with completion scheduled for September 24, 2025. This non-set-aside contract represents a child order under AmerisourceBergen's broader pharmaceutical supply agreements with DLA, leveraging the company's extensive capabilities as a major pharmaceutical distributor to the federal healthcare system. The delivery location is...
- The Defense Logistics Agency awarded a $13,259.50 delivery order to AmerisourceBergen Drug Corp for SCEMBLIX 40 mg tablets (60 count) on October 29, 2025, with completion scheduled for November 20, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award will be fulfilled at AmerisourceBergen's...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded AmerisourceBergen Drug Corp a delivery order valued at $26,519.00 for SCEMBLIX 40 mg tablets (60-count units) on August 12, 2025, with completion scheduled for September 3, 2025. This firm fixed-price, competitively awarded contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $26,519 firm fixed-price delivery order to AmerisourceBergen Drug Corp for SCEMBLIX 40 mg tablets (60-count units) under a competitively awarded, non-set-aside contract. The delivery order, issued on September 22, 2025, carries an ultimate completion date of October 14, 2025, with performance to take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This award represents a routine pharmaceutical procurement fulfilling...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,259.50 to AmerisourceBergen Drug Corp for the supply of SCEMBLIX 40 mg tablets (60-count units) under a firm fixed-price contract. The award was issued on August 14, 2025, with an ultimate completion date of September 5, 2025, and no set-aside designation was utilized. Performance will occur at AmerisourceBergen's Corporate Office facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $53,038 on August 20, 2025, for the supply of SCEMBLIX 40 mg tablets (60-count units) under a firm fixed-price contract with no set-aside designation. The order, which carries an ultimate completion date of September 11, 2025, is funded through the Defense Logistics Agency's Medical Supply Chain and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract...
- The Defense Logistics Agency awarded a $13,259.50 delivery order to AmerisourceBergen Drug Corp for Scemblix 40 mg tablets (60-count units) on August 8, 2025, with an ultimate completion date of August 29, 2025. The contract is structured as a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal...
- The Defense Logistics Agency awarded a $13,259.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for 60 tablets of Scemblix 40 mg, a pharmaceutical product for federal medical supply needs. The contract was competitively awarded without a set-aside designation and is scheduled for completion by October 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for military and veteran healthcare systems through the...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,259.50 fixed-price contract is for the delivery of SCEMBLIX 40 MG TABLET UU 60S, a specialty medication. It is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- SPE2DB25D3306Indefinite Delivery Contract
- SPE2DB25D3306-SPE2DB26FUAPCDelivery Order
The Defense Logistics Agency awarded a $13,259.50 delivery order to AmerisourceBergen Drug Corp for SCEMBLIX 40 mg tablets (60-count units) under a firm fixed-price contract. The award was made on October 31, 2025, with an ultimate completion date of November 24, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs, particularly for military and veteran healthcare systems. This delivery order was competitively awarded without set-aside designation, reflecting the contractor's capability to meet federal procurement requirements in open competition. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The DLA Troop Support Medical Supply Chain leverages this prime vendor arrangement to fulfill critical medication requirements across the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems, with plans to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts across multiple regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.3k | 10/31/25 |